Cargando…
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a tenacious pathogen that has latently infected one third of the world’s population. However, conventional TB treatment regimens are no longer sufficient to tackle the growing threat of drug resistance, stimulating the de...
Autores principales: | Yan, Weizhu, Zheng, Yanhui, Dou, Chao, Zhang, Guixiang, Arnaout, Toufic, Cheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780415/ https://www.ncbi.nlm.nih.gov/pubmed/36547804 http://dx.doi.org/10.1186/s43556-022-00106-y |
Ejemplares similares
-
Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis
por: Mancuso, Giuseppe, et al.
Publicado: (2023) -
Mechanism of catalysis and inhibition of Mycobacterium tuberculosis SapM, implications for the development of novel antivirulence drugs
por: Fernandez-Soto, Paulina, et al.
Publicado: (2019) -
Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
por: Ioerger, Thomas R., et al.
Publicado: (2013) -
Drug Resistance Mechanisms in Mycobacterium tuberculosis
por: Palomino, Juan Carlos, et al.
Publicado: (2014) -
New approaches against the ancient pathogen Mycobacterium tuberculosis
por: EBioMedicine
Publicado: (2021)